Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Effect of Interleukin-2 on HIV Treatment Interruption

This study has been completed.
Information provided by (Responsible Party):
National Institute of Allergy and Infectious Diseases (NIAID) Identifier:
First received: May 1, 2001
Last updated: May 21, 2012
Last verified: May 2012